611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net
Medical Disorders
Resources
Basic InformationLookupsLatest News
AHA News: Women May Be More Willing Than Men to Donate OrgansDNA Sensor Can Spot When COVID Is ContagiousTrials Show COVID Vaccines Well Worth It for Cancer PatientsCDC Endorses Booster Shots for Millions of AmericansChildhood Trauma Linked With Higher Odds for Adult Neurological IllsStudy Probes Relationship Between Migraines and SleepCancer in Hispanics: Good News and BadFDA Approves Pfizer Booster Shots for Seniors, High-Risk AmericansU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationAntibodies to Early Strains of COVID May Not Fight New Variants: StudyPregnant Women Who Get COVID Vaccine Pass Antibodies to NewbornsCDC Expert Panel to Weigh In on Vaccine BoostersWhich Kids Are at Highest Risk From COVID?4 Out of 10 Adults With No Known Heart Disease Have Fatty Hearts: StudyBooster Dose of J&J COVID Vaccine Increases ImmunityPost-Stroke Rehab: There's a Sweet Spot in the TimingCommon Form of Liver Cancer on the Rise in Rural AmericaCOVID Has Killed More Americans Than the Spanish Flu Did in 1918Telemedicine Gets High Marks for Follow-Ups After SurgeryPandemic Tied to Declining Birth Rates for U.S., Much of EuropeStudy Spots People at High Risk of Severe Breakthrough COVIDReview of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: FauciDelta Variant Now Fueling 99% of U.S. COVID CasesLower Dose of Pfizer COVID Vaccine Works Well in Young Children, Company SaysFDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not YoungerLong-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotCommon Eye Conditions Tied to Higher Risk for DementiaDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major Journal
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Who's Most Likely to Refuse a COVID Vaccine?

HealthDay News
by Robert Preidt
Updated: Jul 27th 2021

new article illustration

TUESDAY, July 27, 2021 (HealthDay News) -- COVID-19 vaccine hesitancy among American adults fell by one-third in the first five months of 2021, a new study finds, but distrust of vaccines and the government are still keeping many people from getting vaccinated.

Researchers analyzed data gathered from about 1 million Americans a month between January and May as part of an ongoing national COVID-19 survey. Those who said they would probably not or would definitely not get vaccinated were considered to be vaccine-hesitant.

Who were these people?

In terms of education levels, people with a high school education or less had the largest decrease in vaccine hesitancy during the study period, while hesitancy held constant among those with a PhD, which was the most hesitant group by May.

Vaccine hesitancy fell across nearly all racial groups, with the largest decreases among Black people and Pacific Islanders. By May, they had joined Hispanics and Asians at having lower vaccine hesitancy than white people.

Counties with higher support for Donald Trump in the 2020 presidential election had higher hesitancy rates, and the difference in hesitancy between areas with high and low Trump support grew over the study period, the findings showed.

"This finding really highlights the politicization of public health recommendations," said study first author Wendy King, an associate professor of epidemiology at the University of Pittsburgh.

Senior study author Robin Mejia said, "What's concerning is there is a subset of the population that's got strong levels of hesitancy, as in refusal to take the vaccine, not potential concern about it, and the size of that group isn't changing." Mejia is part of special faculty in Carnegie Mellon University's College of Humanities and Social Sciences.

"I remain concerned about reaching the most hesitant subgroup of Americans," she added. "The only way to end this pandemic for real is to get enough people vaccinated that we can reduce the speed of new variants spreading."

Not trusting the vaccine and not trusting the government were common reasons for not getting vaccinated among the most hesitant, while less hesitant people were more likely to say they wanted to wait to see if the vaccines are safe, the researchers said in a University of Pittsburgh news release.

King pointed out that "in all the other levels of vaccine intent we saw change over time. The lack of change in prevalence of the 'definitely not' group implies those with strong feelings about the vaccine are not likely to change easily. Thinking about how to reach that group, and having messaging and incentives that that group will respond to is important."

The findings were published online July 23 on the preprint website medRxiv and have not been peer-reviewed.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

SOURCE: University of Pittsburgh, news release, July 26, 2021